caprylic triglyceride

DIETARY_SUPPLEMENT2 trials

Sponsors

Cerecin, University of Miami

Conditions

Alzheimer's DiseasePrimary Progressive MSRelapsing Remitting MSSecondary Progressive MS

Phase 2

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

WithdrawnNCT01211782

CerecinAlzheimer's Disease

Updated: 2012-12-04

Unknown Phase

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

CompletedNCT01848327

University of MiamiPrimary Progressive MS, Relapsing Remitting MS, Secondary Progressive MS

Start: 2013-02-28End: 2017-12-31Updated: 2018-01-25